Create marketing funnels in minutes!
Your page? Unpause your account to remove this banner.
Review the full pipeline report
OK, I'd Like The Report.
* we will not spam, rent, or sell your information... *
74% of Medicines in Clinical Development have Potential to be First-in-Class Treatments
A New Report Shows Promise for Patients
What you will find in this free report by The Analysis Group:
As of August 2016, there were more than 6,300 products in clinical development globally
Taking into account that there may be clinical trials underway in more than one indication for a given molecule, these products correspond to over 9,500 projects in clinical development
Development projects were distributed across many therapeutic areas, from cancer to cardiovascular disease and diabetes, to neurology
Approximately three-quarters (74%) of clinical-phase projects were potentially first-in-class
Of the projects in clinical development, 822 were determined to be covered by an orphan drug designation awarded by the FDA
A range of novel scientific approaches to address various diseases and conditions were being pursued in clinical development
Request your copy of the full report here:
Read the Full Report Here
Copyright 2017 - PhRMA